HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tadashi Fujiwara Selected Research

Double Outlet Right Ventricle

11/2008Thrombotic occlusion of Blalock-Taussig shunt in a patient with unnoticed protein C deficiency.
10/2008Surgical palliation for Taussig-Bing anomaly with multiple lesions.
8/2005Successful extensive enlargement of a non-committed ventricular septal defect in double outlet right ventricle.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tadashi Fujiwara Research Topics

Disease

4Ventricular Heart Septal Defects (Ventricular Septal Defect)
12/2010 - 12/2004
3Double Outlet Right Ventricle
11/2008 - 08/2005
2Disease Resistance
09/2014 - 07/2014
2Pathologic Constriction (Stenosis)
10/2008 - 10/2002
2Coronary Artery Disease (Coronary Atherosclerosis)
08/2005 - 10/2002
2Hypertension (High Blood Pressure)
08/2005 - 11/2003
2Tricuspid Valve Insufficiency (Insufficiency, Tricuspid Valve)
08/2005 - 12/2004
1Porcine Reproductive and Respiratory Syndrome (PRRS)
07/2022
1Infections
04/2010
1Hypoplastic Left Heart Syndrome
01/2010
1Heterotaxy Syndrome
01/2010
1Aneurysm (Aneurysms)
03/2009
1Protein C Deficiency
11/2008
1Pulmonary Valve Stenosis (Pulmonary Stenosis)
11/2008
1Thrombosis (Thrombus)
08/2008
1Supravalvular Aortic Stenosis (Aortic Supravalvular Stenosis)
01/2007
1Insulin Resistance
08/2005
1Obesity
08/2005
1Hypertriglyceridemia
08/2005
1Hypercholesterolemia
08/2005
1Pulmonary Hypertension
12/2004
1Ebstein Anomaly (Ebsteins Anomaly)
12/2004
1Heart Failure
12/2004
1Congenitally Corrected Transposition of the Great Arteries
12/2004
1Diabetes Mellitus
11/2003
1Arteriosclerosis
11/2003
1Cardiovascular Diseases (Cardiovascular Disease)
10/2002

Drug/Important Bio-Agent (IBA)

2Glucose (Dextrose)FDA LinkGeneric
08/2005 - 11/2003
1Leucine (L-Leucine)FDA Link
07/2022
1EpitopesIBA
07/2022
1Peptides (Polypeptides)IBA
07/2022
1Peptide Elongation Factor Tu (EF-Tu)IBA
07/2022
1FlagellinIBA
07/2022
1Pattern Recognition ReceptorsIBA
07/2022
1LigandsIBA
07/2022
1Leucine-Rich Repeat ProteinsIBA
09/2014
1Reactive Oxygen Species (Oxygen Radicals)IBA
07/2014
1N-acetylchitooligosaccharideIBA
04/2010
1ChitinIBA
04/2010
1Serotonin (5 Hydroxytryptamine)IBA
04/2010
1SuspensionsIBA
04/2010
1Warfarin (Coumadin)FDA LinkGeneric
11/2008
1Triglycerides (Triacylglycerol)IBA
08/2005
1HDL LipoproteinsIBA
08/2005
1HDL CholesterolIBA
08/2005
1CholesterolIBA
08/2005
1Insulin (Novolin)FDA Link
08/2005
1Blood Glucose (Blood Sugar)IBA
11/2003

Therapy/Procedure

3Fontan Procedure (Fontan Operation)
12/2010 - 08/2008
3Arterial Switch Operation
10/2008 - 12/2004
1Norwood Procedures
01/2010
1Sutures (Suture)
03/2009
1Blalock-Taussig Procedure
11/2008
1Coronary Artery Bypass (Coronary Artery Bypass Surgery)
01/2007
1Stents
10/2002